Evidence map›Paper›PMID 19277880›Full record

ArticleCancer causes & control : CCC2009

Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study.

June M Chan, Furong Wang, Elizabeth A Holly

Open access · hybridAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 5 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 5 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4).Annals of oncology : official journal of the European Society for Medical Oncology · 2017
    Article
  15. Article
  16. Review
  17. Article
  18. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4).Annals of oncology : official journal of the European Society for Medical Oncology · 2012
    Article
  19. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2012
    Article
  20. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4).Annals of oncology : official journal of the European Society for Medical Oncology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

June M ChanDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. june.chan@ucsf.edu
Furong Wang
Elizabeth A Holly
University of California, San Francisco · US

Funding

USE OF VASOACTIVE PEPTIDES TO MODIFY MONOCLONAL ANTIBODY PHARMACOLOGYP50CA072712 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOLLINGSWORTH, MICHAEL A · 1997 to 2004
$5.4M
Pancreas cancer analysis-SF Bay Area case-control studyR03CA108370 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2004 to 2005
$152k
MTHFR POLYMORPHISMS IN PANCREATIC CANCER IN SF BAY AREAR03CA089726 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2002
$148k
PANCREATIC CANCER CASE CONTROL STUDY IN SAN FRANCISCOR01CA059706 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 1994 to 1998
–
NCI NIH HHS CA09889NCI NIH HHS CA108370NCI NIH HHS CA59706NCI NIH HHS CA72712NCI NIH HHS CA89726NCI NIH HHS N01 PC035136NCI NIH HHS N01 PC035139NCI NIH HHS N02 PC015105NCI NIH HHS P50 CA072712NCI NIH HHS R03 CA089726NCI NIH HHS R03 CA108370
6 · The paper itself

Abstract

objectiveWe examined the associations between sweets, sweetened and unsweetened beverages, and sugars and pancreatic cancer risk.

methodsWe conducted a population-based case-control study (532 cases, 1,701 controls) and used multivariate logistic regression models to calculate odds ratios (OR) and 95% confidence intervals (CI). Because associations were often different by sex, we present results for men and women combined and separately.

resultsAmong men, greater intakes of total and specific sweets were associated with pancreatic cancer risk (total sweets: OR = 1.9, 95% CI: 1.0, 3.6; sweet condiments: OR = 1.9, 95% CI: 1.2, 3.1; chocolate candy: OR = 2.4, 95% CI: 1.1, 5.0; other mixed candy bars: OR = 3.3, 95% CI: 1.5, 7.3 for 1 + servings/day versus none/rarely). Sweets were not consistently associated with risk among women. Sweetened beverages were not associated with increased pancreatic cancer risk. In contrast, low-calorie soft drinks were associated with increased risk among men only; while other low-/non-caloric beverages (e.g., coffee, tea, and water) were unassociated with risk. Of the three sugars assessed (lactose, fructose, and sucrose), only the milk sugar lactose was associated with pancreatic cancer risk (OR = 2.0, 95% CI: 1.5, 2.7 comparing extreme quartiles).

conclusionThese results provide limited support for the hypothesis that sweets or sugars increase pancreatic cancer risk.

Indexed as

AdenocarcinomaCaliforniaCarbonated BeveragesCase-Control StudiesConfidence IntervalsFemaleHumansIncidenceInterviews as TopicLactoseLogistic ModelsMaleMultivariate AnalysisOdds RatioPancreatic NeoplasmsRisk FactorsLactoseSweetening Agents

Identifiers

PMID19277880
PMCPMC2694313
OpenAlexW2110674814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.